Aethlon Medical, Inc. (NASDAQ:AEMD) gapped down before the market opened on Friday . The stock had previously closed at $3.53, but opened at $2.76. Aethlon Medical shares last traded at $2.06, with a volume of 4,545,141 shares trading hands.
Separately, ValuEngine raised Aethlon Medical from a “hold” rating to a “buy” rating in a research report on Friday, January 3rd.
The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 4.48. The business has a 50-day moving average price of $1.55 and a 200 day moving average price of $1.34. The stock has a market cap of $2.44 million, a PE ratio of -0.40 and a beta of 0.22.
Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings results on Friday, November 1st. The medical equipment provider reported ($1.29) EPS for the quarter, missing analysts’ consensus estimates of ($1.10) by ($0.19). On average, equities analysts predict that Aethlon Medical, Inc. will post -4.71 earnings per share for the current year.
An institutional investor recently bought a new position in Aethlon Medical stock. Cordasco Financial Network acquired a new stake in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) during the third quarter, according to its most recent filing with the SEC. The fund acquired 203,957 shares of the medical equipment provider’s stock, valued at approximately $47,000. Cordasco Financial Network owned 1.02% of Aethlon Medical as of its most recent filing with the SEC. Institutional investors and hedge funds own 55.97% of the company’s stock.
Aethlon Medical Company Profile (NASDAQ:AEMD)
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.
Further Reading: Why are percentage gainers important?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.